Skip to Main Content

Emmanuelle L. Waubant

MD PhD

Director, Regional Pediatric Multiple Sclerosis Center
Neurologist
International expert on pediatric and adult MS

Dr. Emmanuelle L. Waubant is a neurologist who specializes in treating patients with multiple sclerosis (MS). She serves as director of the UCSF Regional Pediatric Multiple Sclerosis Center.

Waubant's research focuses on new treatments for MS. She also studies environmental and genetic risk factors, including in children with the disease.

A native of France, Waubant earned her medical degree at the Lille University School of Medicine and completed a residency in neurology at Toulouse University Hospital, where she was chief resident as well as junior faculty for two years. She completed fellowships in neuroimmunology and clinical neuroimmunology at UCSF and then returned to her native country to head a clinical research center at the Pitié-Salpêtrière University Hospital in Paris. She joined the UCSF Multiple Sclerosis Center in 2001.

Waubant serves on the clinical care committee of the National Multiple Sclerosis Society's local chapter and on the translational research review committee for the society's national office. She chairs the clinical trial task force and serves on the steering committee of the International Pediatric Multiple Sclerosis Study Group.

A prominent contributor to scientific journals in her field, Waubant is one of two chief editors of Multiple Sclerosis and Related Disorders, and she is MS section editor for Annals of Clinical and Translational Neurology.

Waubant speaks French.

  • Education

    Lille University School of Medicine, 1992

  • Residencies

    Toulouse University Hospital, Neurology, 1992

  • Fellowships

    UCSF Medical Center, Neurology, 1999

  • Academic Title

    Professor

  • Languages

    French

I care for patients with MS, lead research seeking to advance therapies and mentor junior investigators who will be tomorrow's stars in the field.

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    91 Ratings
    Explained things in a way that was easy to understand
    91 Ratings
    Did the doctor pay attention to your concerns
    91 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    88 Ratings
    Knew the important information about your medical history
    90 Ratings
    The provider showed respect for what you had to say
    91 Ratings
    The provider spent enough time with me
    91 Ratings
    Decorative Caduceus

    A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

    NEP is defined as no progression sustained for at least 24 weeks on all of the following three components (confirmed disability progression [CDP]; ≥20% increase in timed 25-foot walk test [T25FWT]; ≥20% increase in nine-hole peg t...

    Recruiting

    Decorative Caduceus

    A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuro...

    Recruiting

    Decorative Caduceus

    Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

    Number of adverse events recorded by system, severity, and by relationship to treatment arm.

    Recruiting

    Decorative Caduceus

    Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

    Time to sustained disability progression is measured by the Expanded Disability Status Scale plus (EDSS+): a composite endpoint that includes EDSS change (change at any 6 month time point of > 1.0 point if baseline EDSS is < 5.5 o...

    Recruiting

    Share